Concepedia

M. Wong

MW

Statistics

Publications

8

Citations

826

H-Index

8

Active since

1989

Affiliations

Eli Lilly (United States)(Current)

University of Michigan

Hôpital Edouard Herriot

Columbia University

University of California, San Francisco

M. Wong is an author at Eli Lilly (United States) specializing in medicine, osteoporosis, and bone health.

Publications per year

1989–2014

8

Publications

8

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

P. D. Delmas, Harry K. Genant, Gerald Crans et al. · Bone · 2003 · 541 citations

, , +11

Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene

P. J. Meunier, E. Vignot, Patrick Garnero et al. · Osteoporosis International · 1999 · 96 citations

, , +13

Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study

Ethel S. Siris, Jonathan D. Adachi, Ying Lü et al. · Osteoporosis International · 2002 · 76 citations

, , +15

Aggrecan core protein is expressed in membranous bone of the chick embryo. Molecular and biomechanical studies of normal and nanomelia embryos.

M. Wong, Theresa A. Lawton, Paul F. Goetinck et al. · Journal of Biological Chemistry · 1992 · 42 citations · Full text

, , +15

Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

M. Wong, Peter G. Wells · Journal of Pharmacology and Experimental Therapeutics · 1989 · 30 citations

, , +14

1–5 of 8